Age: 9.0
Sex: F
Vaccine: HPV4
Symptoms: Speech disorder, Syncope, Weight increased
Clinical narrative: Guillain Barre Syndrome (face dropping, trouble speaking, tingling in her arms and face, numbness, legs weakness, lost the ability to chew and swallow food, trouble breathing, collapsing, joint/knee pain, hallucinations,fatique,changed sleep pattern); Autoimmune Disease (gained weight); Information has been received from a lawyer regarding a case in litigation referring to a 9-year-old female patient (pt). Before receiving her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection, the pt was in her usual state of health. She was full of energy.   On 26-JUL-2017, the pt's healthcare provider recommended to receive the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), which was stated as a safe and effective vaccine for preventing cervical cancer. On the same date, the pt received her first and only dosage of "cervical cancer vaccine" quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, anatomical location, lot # and expiration date were not reported). Within the first three days of receiving the first dosage of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), the pt's  face seemed off and appeared to be dropping at times. She also complained about being extremely fatigued and had trouble speaking. After about a month or so, she started school again. The pt's  father noticed that something was still wrong with her, and with each day, she had more complaints. The pt complained of having tingling in her arms and face and numbness. Her fatigue also increased and changed her sleep pattern. Eventually, the pt could no longer walk home with her siblings as she was experiencing weakness in her legs. On 28-AUG-2017, the pt's father took her to the hospital because her condition worsened. By this time, she had lost the ability to chew and swallow food, and she was having trouble breathing. Within the next month, she started collapsing on the floor. The symptoms would come and go, and within the first few months of the vaccination, the pt had gone to four different hospitals because of her symptoms. On 10-OCT-2017, the pt's symptoms included: fatigue, abnormal body movements, development of joint and knee pain, jaw pain, change in sleep pattern, eye droopiness, hallucinations, visual hallucinations, and gustatory hallucinations. The pt was taken to physician, who diagnosed her with Guillain Barre Syndrome. By this time, the pt had seen many doctors and had been hospitalized numerous times.  Her day-to-day function changed and was not the same as that of a normal child her age. She was not longer able to be physically active or participate in the activities she used to. The pt has gained weight and had difficulty speaking. She remained feeling tired and was currently attending a school with kids with disabilities. The pt sustained autoimmune disease and other serious injuries including but not limited to, Guillain Barre Syndrome (GBS) as a result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection. Vaccination with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) resulted in her suffering from severe, debilitating, disabling and painful chronic injuries. The pt contended that her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection caused her to develop serious and debilitating injuries, including but not limited to GBS, tingling in her arms and face, fatigue, abnormal body movements, inability to chew and walk, joint and knee pain, jaw pain, change in sleep pattern, eye droopiness, hallucinations, visual hallucinations, and gustatory hallucinations as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by vaccine or otherwise linked to her vaccine-induced autoimmune disorder. As a proximate result of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), pt suffered and would continue to suffer severe and permanent physical injuries, and associated symptomology and had suffered severe and permanent emotional injuries, including pain and suffering. The pt also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her autoimmune disease and other injuries caused by this vaccine. As a direct and proximate result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, pt had suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. The outcome of the events was considered to be not recovered. The reporter considered both events to be related to the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  Both events were determined to be disabling.  Upon internal review, the events of GBS and autoimmune disorder were determined to be medically significant.